Suchergebnisse - "Højen, Jesper F"

PubPharm (15)

1

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence : the randomized phase 2a TITAN trial

enthalten in: Nature medicine | 2023

von Gunst, J. | Højen, J. | Pahus, M. | +30

2

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

enthalten in: bioRxiv.org | 2021

von Nielsen, S. | Vibholm, L. | Monrad, I. | +12

3

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

enthalten in: EBioMedicine | 2021

von Nielsen, S. | Vibholm, L. | Monrad, I. | +12

4

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial

enthalten in: EClinicalMedicine | 2021

von Gunst, J. | Staerke, N. | Pahus, M. | +36

5

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

enthalten in: EBioMedicine | 2021

von Vibholm, L. | Nielsen, S. | Pahus, M. | +14

CommentIn: EBioMedicine. 2021 Feb;64:103234. - PMID 33581642

6

cAIMP administration in humanized mice induces a chimerization-level-dependent STING response

enthalten in: Immunology | 2019

von Andersen, A. | Olesen, R. | Jønsson, K. | +9

7

cAIMP administration in humanized mice induces a chimerization‐level‐dependent STING response

enthalten in: Immunology | 2019

von Andersen, A. | Olesen, R. | Jønsson, K. | +9

8

Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals

enthalten in: AIDS (London, England) | 2018

von Winckelmann, A. | Morcilla, V. | Shao, W. | +8

CommentIn: AIDS. 2018 Nov 13;32(17):2649. - PMID 30379693

9

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017

von Vibholm, L. | Schleimann, M. | Højen, J. | +23

CommentIn: Clin Infect Dis. 2017 Jun 15;64(12):1696-1698. - PMID 28329288

10

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

Erschienen: 2017

von Vibholm, L. | Schleimann, M. | Højen, J. | +23